Guardant Health
GH
#3260
Rank
NZ$6.13 B
Marketcap
$49.62
Share price
-3.64%
Change (1 day)
32.37%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Market capitalization of Guardant Health (GH)

Market cap: NZ$6.13 Billion

As of November 2024 Guardant Health has a market cap of NZ$6.13 Billion. This makes Guardant Health the world's 3260th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Guardant Health from 2018 to 2024

End of year Market Cap

Year Marketcap Change
2024NZ$6.13 B18.08%
2023NZ$5.19 B18.31%
2022NZ$4.38 B-70.52%
2021NZ$14.88 B-16.64%
2020NZ$17.85 B63.89%
2019NZ$10.89 B126.72%
2018NZ$4.80 B

End of Day market cap according to different sources

On Nov 16th, 2024 the market cap of Guardant Health was reported to be:

NZ$6.13 Billion
by Nasdaq info icon info icon
NZ$6.13 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
NZ$32.86 B 436.13%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$5.39 B-12.04%๐Ÿ‡บ๐Ÿ‡ธ USA